Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
10,079 results
- DIGITS PilotIndependent statistical analysis of An Initial Study of the Implementation of Digital Therapeutics for Substance Use Disorders in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02981082).
- Dimethyl Fumarate for Obstructive Sleep Apnea: Complete Statistical AnalysisIndependent statistical analysis of Dimethyl Fumarate for Obstructive Sleep Apnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02438137).
- DIODEIndependent statistical analysis of De-Implementing Opioids for Dental Extractions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03584789).
- DIPIndependent statistical analysis of Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- DIRECTComplete statistical analysis of DIRECT (NCT00252694), a randomized phase 3 trial of candesartan in type 2 diabetes, including trial design, diabetic retinopathy endpoint definition, log-rank analysis, hazard ratio, confidence interval, p-value, and…
- DIRECTComplete statistical analysis of the DIRECT phase 3 trial of candesartan in participants with type 1 diabetes, including trial design, diabetic retinopathy progression, time-to-event methodology, hazard ratio interpretation, and safety.
- DIRECTComplete statistical analysis of the DIRECT trial of candesartan versus placebo in type 1 diabetes, including trial design, ETDRS retinopathy endpoint, log-rank analysis, hazard ratio, confidence interval, p-value, safety, and statistical interpretation.
- Direct Application of Systane Complete to Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Direct Application of Systane Complete to Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03848221).
- Direct Comparison of Spinal Cord Stimulator Parameter Settings: Complete Statistical AnalysisIndependent statistical analysis of Direct Comparison of Spinal Cord Stimulator Parameter Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05283863).
- Direct Current Cathode and Anode Effects and Changes in Handgrip Strength. Evaluation Through a Dynamometer Test: Complete Statistical AnalysisIndependent statistical analysis of Direct Current Cathode and Anode Effects and Changes in Handgrip Strength. Evaluation Through a Dynamometer Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- DIRECT IIIndependent statistical analysis of Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Discontinuing NSAIDs in Veterans With Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Discontinuing NSAIDs in Veterans With Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01799213).
- DISCOVERIndependent statistical analysis of the DISCOVER phase 3 trial evaluating F/TAF versus F/TDF for HIV-1 pre-exposure prophylaxis, including non-inferiority testing, rate-ratio analysis, BMD, renal biomarkers, and statistical methodology.
- Discrete Versus Rhythmic Gait Training: Complete Statistical AnalysisIndependent statistical analysis of Discrete Versus Rhythmic Gait Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02650440).
- Dispatcher-Activated Neighborhood Access Defibrillation and Cardiopulmonary Resuscitation: Complete Statistical AnalysisIndependent statistical analysis of Dispatcher-Activated Neighborhood Access Defibrillation and Cardiopulmonary Resuscitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02010151).
- Dispensing Evaluation of Investigational Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Dispensing Evaluation of Investigational Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02625220).
- Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02065453).
- Disposable Powered Articulating Linear Cutter Stapler in Total-Thoracoscopic Anatomic Lobectomy (Segmentectomy): Complete Statistical AnalysisIndependent statistical analysis of Disposable Powered Articulating Linear Cutter Stapler in Total-Thoracoscopic Anatomic Lobectomy (Segmentectomy): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DISSOLVE IIndependent statistical analysis of A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Distal Renal Denervation: Complete Statistical AnalysisIndependent statistical analysis of Distal Renal Denervation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02667912).
- DIVAIndependent statistical analysis of D Vitamin Intervention in VA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01375660).
- DIVAIndependent statistical analysis of Dual Site Left Ventricular (LV) Pacing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00944125).
- DIVERGENCE 1Independent statistical analysis of Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- DIVERSEIndependent statistical analysis of Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- DIVERTIndependent statistical analysis of Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DIYIndependent statistical analysis of Developing Inclusive Youth: Promoting Intergroup Friendships and Inclusive Classrooms in Childhood: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DKP 3M SCIndependent statistical analysis of Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- DLR PilotIndependent statistical analysis of Study of a Behavioral Intervention for Older Advanced Cancer Patients and Their Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- DLSEAIndependent statistical analysis of Improvement in Pain,Function and HRQoL ( Health Related Quality of Life) in Subacute Low Back Pain: A Controlled Clinical Trial of Exercise vs NSAIDs (Nonsteroidal Antiinflammatory): primary endpoint…
- DOAC LVADIndependent statistical analysis of Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- DOANIndependent statistical analysis of Cognitive and Emotional Skills to Aid Smoking Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03058991).
- DOC-MEKIndependent statistical analysis of Docetaxel With or Without AZD6244 in Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01256359).
- Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer: primary endpoint results, effect estimate with confidence interval,…
- Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway: primary endpoint results, effect estimate with confidence interval,…
- Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01382706).
- Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck: primary endpoint results, effect estimate with confidence interval,…
- Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency: primary endpoint results, effect estimate with confidence interval,…
- Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval,…
- Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DOCSIndependent statistical analysis of Depression Outpatient Cardiology Screening Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01552889).
- Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?: Complete Statistical AnalysisIndependent statistical analysis of Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?: Complete Statistical AnalysisIndependent statistical analysis of Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty?: Complete Statistical AnalysisIndependent statistical analysis of Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02005601).
- Does Improving Vagal Tone Increase Mitochondrial Bioenergetics: Complete Statistical AnalysisIndependent statistical analysis of Does Improving Vagal Tone Increase Mitochondrial Bioenergetics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03931330).
- Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett’s Esophagus Following Ablation?: Complete Statistical AnalysisIndependent statistical analysis of Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?: Complete Statistical AnalysisIndependent statistical analysis of Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?: Complete Statistical AnalysisIndependent statistical analysis of Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…